News & Articles
Second Time’s The Charm — Navigating NDA Submission, Plus A Resubmission Rescue Mission
The article outlines the challenges faced by a biopharmaceutical company during its […]
Read More....Rare Disease Clinical Endpoints: Ingenuity Meets Practicality
Discover why the science that brought you to this point can only […]
Read More....Why the Regional Site Manager Is the Swiss Army Knife of Clinical Trial Monitoring
The Regional Site Manager (RSM) monitoring model enhances clinical trial oversight by […]
Read More....Top 5 Considerations For CAR-T Trials During A Macroeconomic Downturn
Navigating CAR-T cell therapy trials during economic downturns requires strategic approaches to […]
Read More....Modernize TMF Culture to Better Support Modern Clinical Trials
The article focuses on the need to modernize Trial Master File (TMF) […]
Read More....Identifying The Best People To Run A Clinical Study (And How To Hire Them)
The article emphasizes the importance of identifying and hiring top talent to […]
Read More....Great Size ≠ Great Value: How Smaller Outsourcing Partners Benefit Small And Emerging Biotechs
The article highlights the advantages of partnering with smaller outsourcing firms for […]
Read More....What Big CROs Don’t Want You To Know About Staffing Scalability For Phase III Studies
The article addresses the hidden challenges of staffing scalability in Phase III […]
Read More....The Fallacy of the Corporate Memory Concept
The article challenges the concept of “corporate memory” within large CROs, arguing […]
Read More....Do You Take Comfort In Governance Agreements
The article delves into the limitations of governance agreements with large CROs, […]
Read More....